9th International Conference and Exhibition on Pharmacovigilance & Drug Safety
University of Bologna, Italy
Fiorenza Stagni is a Postdoctoral Fellow at the Department of Biomedical and Neuromotor Sciences of the University of Bologna (Italy). In 2014 she obtained her PhD in Biomedical Sciences. In the framework of her doctoral work, she examined the effects of perinatal therapies on the neurodevelopmental alterations that characterize Down syndrome (DS), exploiting a mouse model of this pathology. She is currently involved in an international project aimed at identifying a panel of drugs that may be safely used during pregnancy or in infants in order to counteract the neurodevelopmental defects linked to DS. In 2016 she was awarded by the
Trisomy 21 Research Society for the best dissertation in the field of DS (defended in 2014-2015). During the last years, she has received several Travel Awards for her the participation to international congresses and she was author of 13 publication in the field of preclinical studies for DS.